REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jetema Co., Ltd. (South Korea)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Jetema Co., Ltd. Profile Updated: July 04, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Jetema Co., Ltd. is engaged in provision of developing and researches cosmetic medicines. The company also offers products such as collagen injection, clostridium botulinum, and other products. Jetema Co., Ltd. was incorporated in 2009 and is based in Wonju, South Korea.

Headquarters
1283-4, Gagok-ri Jijeong-myeon Wonju-si Gangwon
Wonju; Gangwon;

Contact Details: Purchase the Jetema Co., Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Jetema Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Jetema Co., Ltd. report to view the information.
Registered Capital:
Purchase the Jetema Co., Ltd. report to view the information.
Incorporation Date:
July 17, 2009
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Senior Managing Director
Company Performance
Financial values in the chart are available after Jetema Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
38.44%▲
Total operating revenue
38.44%▲
Operating profit (EBIT)
75.77%▲
EBITDA
61.5%▲
Net Profit (Loss) for the Period
-86.63%▼
Total assets
27.33%▲
Total equity
4.37%▲
Operating Profit Margin (ROS)
1.85%▲
Net Profit Margin
-29.6%▼
Return on Equity (ROE)
-17.39%▼
Debt to Equity Ratio
-17.61%▼
Quick Ratio
-2.5%▼
Cash Ratio
-2.22%▼

Similar companies

Msd Korea Ltd.
 
Abbott Diagnostics Korea Co.,Ltd.
Donga Pharmaceutical Co.,Ltd.
 
Bionote Co.,Ltd.
Rapi Gen Co.,Ltd.
 
Hana Pharm Co.,Ltd.
Pharma Research Bio Co. Ltd.
 
Optipharm Co.,Ltd
Bio-Fd&C Co.,Ltd.
 
Pangen Biotech Inc.
Inventage Lab Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo